Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-07
2007-08-07
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S207000, C546S208000, C546S209000, C546S210000, C546S211000, C546S190000, C544S129000, C544S283000, C514S316000, C514S235500, C435S007200
Reexamination Certificate
active
10601070
ABSTRACT:
Disclosed herein are compounds of Formula I,or a pharmaceutically acceptable salt, amide, ester, or prodrug thereof. Also disclosed are methods of inhibiting an activity of a monoamine receptor comprising contacting the monoamine receptor or a system containing the monoamine receptor with an effective amount of one or more of the compounds of Formula I. Disclosed are also methods of inhibiting an activation of a monoamine receptor comprising contacting the monoamine receptor or a system containing the monoamine receptor with an effective amount of one or more of the compounds of Formula I. Furthermore, methods of treating psychotic disease using a compound of Formula I are disclosed.
REFERENCES:
patent: 3983234 (1976-09-01), Sayers
patent: 4138492 (1979-02-01), Noverola et al.
patent: 4255432 (1981-03-01), Kluge et al.
patent: 4332804 (1982-06-01), Clark
patent: 4353900 (1982-10-01), Clark
patent: 4367232 (1983-01-01), Boix-Igleasias et al.
patent: 4853394 (1989-08-01), King et al.
patent: 5025013 (1991-06-01), Barreau et al.
patent: 5214055 (1993-05-01), Peglion et al.
patent: 5216165 (1993-06-01), Mobilio et al.
patent: 5461066 (1995-10-01), Gericke
patent: 5595872 (1997-01-01), Wetterau, II et al.
patent: 5621010 (1997-04-01), Sueda et al.
patent: 5707798 (1998-01-01), Brann
patent: 5795894 (1998-08-01), Shue et al.
patent: 5869488 (1999-02-01), Shue et al.
patent: 5877173 (1999-03-01), Olney et al.
patent: 5912132 (1999-06-01), Brann
patent: 5955281 (1999-09-01), Brann
patent: 6107324 (2000-08-01), Behan et al.
patent: 6140509 (2000-10-01), Behan et al.
patent: 6150393 (2000-11-01), Behan et al.
patent: 6358698 (2002-03-01), Weiner et al.
patent: 6756393 (2004-06-01), Andersson et al.
patent: 6815458 (2004-11-01), Andersson et al.
patent: 6911452 (2005-06-01), Schlienger
patent: 7041667 (2006-05-01), Armour et al.
patent: 7115634 (2006-10-01), Thurieau et al.
patent: 2002/0004513 (2002-01-01), Andersson et al.
patent: 2002/0165225 (2002-11-01), Hamied et al.
patent: 2004/0006081 (2004-01-01), Burrows et al.
patent: 2004/0006089 (2004-01-01), Christophe et al.
patent: 2004/0213816 (2004-10-01), Weiner et al.
patent: 2005/0014757 (2005-01-01), Andersson et al.
patent: 2005/0148018 (2005-07-01), Weiner et al.
patent: 2005/0244862 (2005-11-01), Brann
patent: 2005/0256108 (2005-11-01), Schlienger
patent: 2006/0094758 (2006-05-01), Andersson et al.
patent: 2006/0106063 (2006-05-01), Thygesen et al.
patent: 2006/0111399 (2006-05-01), Thygesen et al.
patent: 2006/0194778 (2006-08-01), Andersson et al.
patent: 2006/0194834 (2006-08-01), Andersson et al.
patent: 2006/0199794 (2006-09-01), Schlienger
patent: 2006/0199818 (2006-09-01), Andersson et al.
patent: 2006/0199842 (2006-09-01), Weiner et al.
patent: 2006/0205710 (2006-09-01), Schlienger et al.
patent: 2006/0205722 (2006-09-01), Andersson et al.
patent: 2006/0205780 (2006-09-01), Thygesen et al.
patent: 2006/0205781 (2006-09-01), Thygesen et al.
patent: 984843 (1976-03-01), None
patent: 0005318 (1979-11-01), None
patent: 0061333 (1982-09-01), None
patent: 0379441 (1990-07-01), None
patent: 0548015 (1993-06-01), None
patent: 0 260 070 (1993-08-01), None
patent: 0625507 (1994-11-01), None
patent: 2 802 206 (2001-06-01), None
patent: 157325 (1998-03-01), None
patent: 94/27967 (1994-12-01), None
patent: 97/08166 (1997-03-01), None
patent: 97/11940 (1997-04-01), None
patent: 97/38665 (1997-10-01), None
patent: 97/38984 (1997-10-01), None
patent: 98/17646 (1997-10-01), None
patent: 98/11128 (1998-03-01), None
patent: 98/44921 (1998-10-01), None
patent: 98/50534 (1998-11-01), None
patent: 99/52927 (1999-10-01), None
patent: 00/23076 (2000-04-01), None
patent: 00/56335 (2000-09-01), None
patent: 00/59497 (2000-10-01), None
patent: 00/69810 (2000-11-01), None
patent: 01/44191 (2001-06-01), None
patent: 01/66521 (2001-09-01), None
patent: 01/87839 (2001-09-01), None
patent: 02/079186 (2002-10-01), None
patent: 03/057698 (2003-07-01), None
patent: 03/057698 (2003-07-01), None
patent: 03/062206 (2003-07-01), None
patent: 03/062206 (2003-07-01), None
patent: 03/070246 (2003-08-01), None
patent: WO 03/086400 (2003-10-01), None
patent: 2004/000808 (2003-12-01), None
patent: 2004/000808 (2003-12-01), None
patent: 2004/064738 (2004-08-01), None
patent: 2004/064738 (2004-08-01), None
patent: 2004/064753 (2004-08-01), None
patent: 2005/063254 (2005-07-01), None
patent: 2005/112927 (2005-12-01), None
patent: 2006/036874 (2006-04-01), None
patent: 2006/037043 (2006-04-01), None
Alvisi, Sulla formazione di derivati pirazolici dalle dicloridrine e dalla tribromidrina della glicerina ordinaria, Gazz. Chem. Ital. 22:59 (1892).
Antilla & Buchwald, Copper-catalyzed coupling of arylboronic acids and amines, Org. Lett. 3:2077-2079 (2001).
Antilla, et al., The copper-catalyzed N-arylation of indoles, J. Am. Chem. Soc. 124:11684-11688 (2002).
Artico, et al., Aromatic hydrazides as specific inhibitors of bovine serum amine oxidase, Europ. J. Med. Chem. Chim. Ther. 27:219-228 (1992).
Barchas, et al., Serotonin and Behavior (1973).
Barnes and Sharp, A review of central 5-HT receptors and their function, Neuropharmacology, 38:1083-1152 (1999).
Barr, D.R., Manning, A.J., Agonist-independent activation of G2by the 5-hydroxytryptamine1Areceptor co-expressed inspodoptera frugiperdacells, Biol. Chem. 272:32979-87 (1997).
Biagi et al., Farmaco Ed. Sci. 43:597-612 (1988).
Bond et al., Physiological effects of inverse agonists in trangenic mice with myocardial overexpression of the2-adrenoceptor, Nature 374:272 (1995).
Brown et al., Catalytic alkylation of aniline, J. Am. Chem. Soc., 46:1836-1838 (1924).
Büchi and Wüest, Synthesis of (±)-nuciferal, J. Org. Chem. 34:1122-1123 (1969).
Buu-Hoi et al., Further studies in the alkylation of phenols and thiophenols, J. Org. Chem. 16:988 (1951).
Cacchi et al., Palladium-catalyzed reaction of aryl iodides with acetic anhydride. A carbon monoxide-free synthesis of acetophenones, Org. Lett. 5:289-293 (2003).
Carman R.M. et al., A further synthesis of an analogue of the antifuncal/antiherbivore lipid from avocado, Aust. J. Chem. 51:955 (1998).
Carroll et al., Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol, J. Med. Chem. 35:2184-91 (1992).
Catarzi et al., Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-0173, J. Med Chem. 44:3157-3165 (2001).
Cerione et al., The mammalian2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system, Biochemistry 23:4519-25 (1984).
Brann, Identification of ligands by selective amplification of cells transfected with receptors and marker enzymes, Chem. Abstr. 128:111548 (1998).
Cherkasov et al., Organothiophsphorus reagents in organic synthesis, Tetrahedron 41:2567 (1985).
Dunn et al., Analgetic and antiinflammatory 7-aroylbenofuran-5-ylacetic acids and 7-aroylbenzothiphene-5-ylacetic acids, J. Med. Chem. 29:2326 (1986).
Emerson, W.S. and Walters, P.J., The reductive alkylation of aniline, J. Am. Chem. Soc. 60:2023 (1938).
Finar, I.L. and Godfrey, K.E., The preparation and properties of some derivatives of I-phenylpyrazole, J. Chem. Soc. 2293 (1954).
Glennon, Serotonin receptors: clinical implications, Neurosci. Biobehavioral Rev. 14:35 (1990).
Gooβen, L.J. and Ghosh, K., Palladium-catalyzed synthesis of aryl ketones from boronic acids and carboxylic acids or anhydrides, Angew. Chem. Int. Ed. Engl. 40:3458-3460 (2001).
Guthrie et al., The tetrahedral intermediate from the hydration of N-methylformanilide, Can. J. Chem. 71:2109-2122 (1993).
Hartwig, Transition metal catalyzed synthesis of arylamines and aryl ethers from aryl halides and triflates: scope and mechanism, Angew. Chem. Int. Ed. 37:2046-2067 (1998).
Hickinbottom, The preparation of secondary alkylaryl-amines and their purification, J. Chem. Soc. 992 (1930).
Hirst, H.R. and Cohen, J
Andersson Carl-Magnus
Fejzic Alma
Hansen Eva Louise
Pawlas Jan
Schlienger Nathalie
Aulakh Charanjit S.
Knobbe Martens Olson & Bear LLP
LandOfFree
N-substituted piperidine derivatives as serotonin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted piperidine derivatives as serotonin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted piperidine derivatives as serotonin receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3898837